OpenVSafe by OpenVAERS
Search V-safe

Y76-95310-90633

4 vaccinations 5 coded responses 28 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
762 / TX
Registered
2021-04-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-06
    Registered in v-safe
  2. 2021-04-06
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-06
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  7. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Nausea · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-13
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  10. 2021-04-20
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-27
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-29
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  15. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-06
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-05-13
    Survey response — day 14, dose 2
    MedDRA: Headache — Feeling: Good
    Free text: Different kind of headache fromvwhat I usually have, the last two days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-27
    Survey response — day 28, dose 2
    MedDRA: Headache — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: Headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-29
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-10-30
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-12-20
    Dose 3 — Pfizer-BioNTech
  27. 2022-04-29
    Survey response — 12 months, dose 2
    MedDRA: Cough, Fatigue, Laryngitis, Office visit, Pain, SARS-CoV-2 test, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Had a cough that progressed to laryngitis and sinus infection. Fatigue and body aches. This was teated for covid by my employer.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-06-20
    Survey response — 6 months, dose 3
    MedDRA: Ageusia, Asthenia, Bone pain, COVID-19, Cough, Fatigue, Feeling cold, Headache, Hyperhidrosis, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid-19 - come-and-go low-grade fever, headache, bone aches, coldness, body sweats, weakness, fatigue, partial loss of taste, cough, congestion,
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-09-17
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  30. 2022-10-23
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  31. 2022-10-29
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  32. 2022-12-17
    Survey response — 3 months, dose 4
    MedDRA: Adverse reaction, Cough, Dysphagia, Increased viscosity of upper respiratory secretion, Nocturnal dyspnoea, Paranasal sinus discomfort, Respiratory tract congestion, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Upper respiratory infection. Heavy coughing, heavy congestion, difficulty breathing at night, sinus pressure, overly thick sticky mucus affecting swallowing. Never any fever. Believe to be allergies.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2023-03-19
    Health check-in — 6 months, dose 4
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-06Pfizer-BioNTech
22021-04-29Pfizer-BioNTech
32021-12-20Pfizer-BioNTech No
42022-09-17Pfizer-BioNTech Flu

Free text

Release 8 — day 14, dose 2

2021-05-13

Symptoms: Different kind of headache fromvwhat I usually have, the last two days.

Release 8 — day 28, dose 2

2021-05-27

Symptoms: Headaches

Release 11 — 12 months, dose 2

2022-04-29

Symptoms: Had a cough that progressed to laryngitis and sinus infection. Fatigue and body aches. This was teated for covid by my employer.

Release 12 — 6 months, dose 3

2022-06-20

Symptoms: Covid-19 - come-and-go low-grade fever, headache, bone aches, coldness, body sweats, weakness, fatigue, partial loss of taste, cough, congestion,

Release 12 — 3 months, dose 4

2022-12-17

Symptoms: Upper respiratory infection. Heavy coughing, heavy congestion, difficulty breathing at night, sinus pressure, overly thick sticky mucus affecting swallowing. Never any fever. Believe to be allergies.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse reaction · · ✓
SDAgeusia · · ✓
SDAsthenia · · ✓
SDBone pain · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDysphagia · · ✓
SDFatigue · · ✓
SDFeeling cold · · ✓
SDHeadache ✓ ✓ ✓
SDHyperhidrosis · · ✓
SDIncreased viscosity of upper respiratory secretion · · ✓
SDLaryngitis · · ✓
SDNocturnal dyspnoea · · ✓
SDOffice visit · · ✓
SDPain · · ✓
SDParanasal sinus discomfort · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test · · ✓
SDSinusitis · · ✓
SDUpper respiratory tract infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release